TET2 and glioblastoma: The expression of TET2, in tumor samples such as BRCA, COAD, HNSC, KIRP, READ, and THCA, was lower, while in CHOL, GBM, KIRC, and UCEC tumors, it was significantly higher than that in corresponding normal control tissues (Figure 1C).